Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pheromone receptors are a specialized class of G protein-coupled receptors (GPCRs) that detect chemical signals known as pheromones, which mediate social and reproductive behaviors within a species [1, 2]. In most mammals, these receptors are located in the vomeronasal organ (VNO), but in humans, the VNO is often considered vestigial, and many pheromone receptor genes have become pseudogenes [2, 3]. However, a subset of Vomeronasal type-1 receptors (VN1Rs) remains functional and is expressed in the human olfactory mucosa, where they are thought to influence the limbic system and modulate emotional responses [3, 4]. These receptors have emerged as novel therapeutic targets for neuropsychiatric conditions, particularly social anxiety disorder and depression [5]. Investigational drugs like Aloradine (PH94B) and Itruvazert (PH10) are designed as nasal sprays to bind these receptors and rapidly modulate neural circuits involved in fear and mood without systemic absorption [5, 6]. Despite this progress, the extent of pheromone-driven behavior in humans and the precise mechanism of these receptors remain areas of active investigation [2, 4].
Agonist of vomeronasal type-1 receptors in the nasal passages, leading to rapid modulation of the limbic system and amygdala activity to reduce anxiety or improve mood.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal type-1 receptor (VN1R).